{"name":"Frontier Biotechnologies Inc.","slug":"frontier-biotechnologies-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Baseline ART","genericName":"Baseline ART","slug":"baseline-art","indication":"Treatment of HIV-1 infection in adults and children","status":"phase_2"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"AB001","genericName":"AB001","slug":"ab001","indication":"Metastatic non-small cell lung cancer, PD-L1 positive","status":"phase_2"}]}],"pipeline":[{"name":"Baseline ART","genericName":"Baseline ART","slug":"baseline-art","phase":"phase_2","mechanism":"Baseline ART works by suppressing the replication of the human immunodeficiency virus (HIV) through the inhibition of reverse transcriptase.","indications":["Treatment of HIV-1 infection in adults and children","Prevention of mother-to-child transmission of HIV"],"catalyst":""},{"name":"AB001","genericName":"AB001","slug":"ab001","phase":"phase_2","mechanism":"AB001 is a small molecule that targets the PD-1 receptor.","indications":["Metastatic non-small cell lung cancer, PD-L1 positive","Metastatic melanoma"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOWTRDMHV5MlBRbGFMLTZzRVZOU01NcnJlOTE0eFZDWHMyeGZvdDRpVUdJTS1XOUVjS3g4cXpoUnNlZVJTOUNTd0pBR1l0ajlNY1FTTHdwRHVRZXRpbzA2SkdsNWNjVE82LUhFU0V3YTZQeUFFUVlycmQ5YngyU2MtVm5lZFpVSG9Ca0p6Qk0ydlFSOFpVVmxkcQ?oc=5","date":"2026-04-08","type":"pipeline","source":"BioWorld News","summary":"New China biotech Syneron chases macrocycle frontier - BioWorld News","headline":"New China biotech Syneron chases macrocycle frontier","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxORkxHUUhJeFlWeDl4MUZxMG1NU1d2dEJQaEhDZXhjYTZDUkI3Z2dIcTVPZEtDRXI2UnY5MnIxWUQ4OU5SNXBuc1ZHNDFhRk15NjQ5b3RqR3BqTl9RVzQ4Qk1Yc0RiY29pS3pkQkw5MS1VanB6NDhMYUFBZi1nWS1VSTFsMnNUVkhOUWpqSDF5TE4xSzlocTJWdEVXaTVNWGtZd0FQMlZKVUgyRFhwOG5vNFRUZHZMdG9kLTlXM1hHV3AtX21tRk16ZkhhckdnOVUtMW1FNklkY2k?oc=5","date":"2026-04-01","type":"pipeline","source":"Barchart.com","summary":"COVID-19 Treatment Pipeline Shows Strong Momentum as 180+ Pharma Companies in the Race | DelveInsight - Barchart.com","headline":"COVID-19 Treatment Pipeline Shows Strong Momentum as 180+ Pharma Companies in the Race | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxPaFZLQks4SGFSY0djZ2dWa01Va0pXSWVRRXUyTDVudksxQ3poYUM0YTJ4WUJ5Mm5IM2U1SGdtY0dkNURaSHItd2NEdmVYanhMTjdrTnp6dTQ3T0R4TU05eFRTSDNpd2Q5LUdEcXdrQm0yX0lvNlA3V3dpSGdyaXRBUGN6OXQwU05JVEhjUGFnQ2VBa25VMVVwekMydkwwUzdVQmxCM0hfY3lKY1NGZFZ4ZzRSUkRLdFg1UTFOS25XNDY4UVdGWmc?oc=5","date":"2026-03-24","type":"pipeline","source":"Markets Mojo","summary":"Frontier Biotechnologies Hits Day Low of CNY 18.27 Amid Price Pressure - Markets Mojo","headline":"Frontier Biotechnologies Hits Day Low of CNY 18.27 Amid Price Pressure","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxOalE1NXJGOXZTM2M4VWcxRE5RSTMwTkhkR3dfa0Q1OEM3MTdKejRkWE16SndRN2IxR0N5UldTZC1ucUN3eUFya2Y4MzduZVEwcDBSMjltcEZWV3BNcDY1eUp0V2dZelNZOURyVVQyWElQWE9UX01Eek1BTmhWcDdvWHA5ZG93VEVFQWVTMGNvMDFJM1o3aVhpQlF3?oc=5","date":"2026-03-03","type":"deal","source":"BioWorld News","summary":"GSK nabs two Frontier Biotech siRNA assets in $1B deal - BioWorld News","headline":"GSK nabs two Frontier Biotech siRNA assets in $1B deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxPWE5PeDl6VGpTS2dfMDZUcVk1STN4LUhpdkJwS19NX0RCamlac2NzbGw5N3hkdTg1Q2xUd1VHLWZTQjdpLXlIdXhycFIycnMwSWxxRXlVcDNMblQtTEVnRjlSXzdvNHVzUThNN3VBMExMRnB0QmlhUmRWSXh0Y1RiZnhka3ZNTmtHekcydVJoSXNGS3EzM2RBNExyRVhuMTh0SzdFc1JGdzBKRVNTNVRnamlTQkYxQXlQOTczUzl3aEZ2WDZ1WUJfZllBb0diSWZmMDJBUFpsdzNIak9UcWRNREYzdll2SjJWT2ZORFBxQkdSWk1tRGww?oc=5","date":"2026-03-03","type":"deal","source":"Citeline News & Insights","summary":"Deal Watch: Esperion Augments Cardiovascular Franchise Via Corstasis Buyout - Citeline News & Insights","headline":"Deal Watch: Esperion Augments Cardiovascular Franchise Via Corstasis Buyout - Citeline News & Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPMU1Tdkc1X1R2T3U3UE1Sa1RaR0JHcERMR3dkcE0zbXlYWjJ2dEM2SnNsSVlQUmM1TG1maENsbjBneDNjLUs5Nmg5NW9IQTVmSUs5SnVuM0ZjMmYzaGRnSnI2dkMyVDUzT1VkYnhQS0lPYUdpSWp3Zk80ZUMyVzFJSTB1b3NsMzRnVGRBT1NTOWZYeXZaMEduaGRLQzFJRk43RG5xMVhTYXVlQ2NUZmpvTklKMmF2OFRBdW85NmM2MnJmdw?oc=5","date":"2026-02-27","type":"pipeline","source":"Caixin Global","summary":"In Depth: China’s Biotech Push Into Small Nucleic Acid Drugs Draws Global Pharma - Caixin Global","headline":"In Depth: China’s Biotech Push Into Small Nucleic Acid Drugs Draws Global Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxQSmNvcG5Uamc5bUIweUw2cjBVUEdydUdJV2IzTUVCMHN4ZWpobVNhOUdwVUtyc193MXlfNXN5TW00d2s3VXdiUFJ6bk9qdFFVdWFtVXl2QW0xbmdNaDE3ajBsbDU5a1QyMXhSaFZnN2NVU3h3OTdvWG1nYzFtVTU0UXBjdXpqUXNCeW50U1gtNDJLcjZZdzkxZUFQZ3hhYWZzcWwxRGpUYi0zWHN2ZXhyNzZxZWlwUHl0YU1QMlp1LVExYWtEMHNfcE4wOEk1cHJzMHlhR09n?oc=5","date":"2026-02-27","type":"deal","source":"BioSpectrum Asia","summary":"China's Frontier Biotech inks $963 M deal with GSK for small interfering RNA therapeutics - BioSpectrum Asia","headline":"China's Frontier Biotech inks $963 M deal with GSK for small interfering RNA therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxQQ05LQ2d4bmpQeGwyUHFYajhQbTNUaTZzdHZoXzV1RXFZc0JNR0hJelhtMDVxeXhObXd2eFVlQ3AwVWdqN1RsUjNSbzVnNW1rQ2FPVkNVS29FQU5VMUc3bkhWOTdfNllwYkNvRGJjb2hkdWlNbjZNSHdCaFhkbGFnRmRpUjNtQ1ZqalA1ZGRxTDhWZURJZ1JpcGo4SW9Qd0Q1bkxRa3ZmcC1DSGRKZzRpNE5yc3dYUjltR3lrSjV4M0h1Wk4tUWR4NVRjNnlwVnNiVk5BMXVCdWxhTzNldXc?oc=5","date":"2026-02-25","type":"pipeline","source":"dailyjournal.com","summary":"The final frontier of drug development: Biotechnology and pharmaceutical innovation in low earth orbit - dailyjournal.com","headline":"The final frontier of drug development: Biotechnology and pharmaceutical innovation in low earth orbit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPN0FacjVYenlNdlVXN2VkT1AwS2JteDNHRWlkLUFiQkkxWUx0dnpVejBLbWtseHNDa09OSHl1TnNZZDQwVjRtVGhMelpPdVYzS0N0WDluLVV4RFpNV19rTWJXbUJCLVNraTZSeElIOG1YcFV6amdXMXoxemhtSnQxSk1oUndvY3N0T1ZPdzV6MGV3WG5Bb3Fna1VMQ3JqQQ?oc=5","date":"2026-02-24","type":"deal","source":"Pharmaceutical Technology","summary":"GSK backs siRNA modality through $1bn Frontier deal - Pharmaceutical Technology","headline":"GSK backs siRNA modality through $1bn Frontier deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE9iVUFUYkF6aGt3akxZT0hGaW1LLTVITDlQdFFCYUZkc2IwaDJKSHZpQ1d2VmtPWldraV9yWm9idUZab0xqcWZzdXllQ1BIaF9WUGVxcFJMNWhPakFld2QzRVg2dElTbkZjVjdzcEY3QmtFRG96SzhTT25aMkY?oc=5","date":"2025-12-17","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Layoff Tracker 2025: Voyager jettisons 30 staffers; Mythic and Areteia shutter - Fierce Biotech","headline":"Fierce Biotech Layoff Tracker 2025: Voyager jettisons 30 staffers; Mythic and Areteia shutter","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQU1dqcmZ2ZkFWMGU2WVlXUmtKVUNHbUVDa05VYmJOaE51TW42MlJQS05uaHRMWHZ3MTU0Q1lMUklfY2pfemYzUGUzVWhCNGhkd08yc2FLMFNNUElxTWlkSlhZSVV3NG9EMll1VnBtTFRVLWFVTGxPT2tpckR4U0dJLS1WSXMxX05fbkg3ckIxOFBpR01VbGd0bFAySExQRVA5VlZiMnNlQUNzNmN5Um1RSFhVQ25Xam5N?oc=5","date":"2025-11-24","type":"deal","source":"BioPharma Dive","summary":"Biogen strikes deal with Versant-backed biotech to expand immune portfolio - BioPharma Dive","headline":"Biogen strikes deal with Versant-backed biotech to expand immune portfolio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQWUdOb0hUeHh2ODhtZXd0VmFzdmVFcHh6Vnl2R3NDY3ZpaDhQZ2RDMFJ4RDAxV0I5VUM4SEZUQWE4dmlmS0JaOWtnbXQ5V3g3QndoVFBIOGd5MFhxZEl5X1I5Y0k2ald3WXRRYm1zNjBZRWw5b0xpSzdQRDAyUmpKeXNRWFZYYzNNdHFOVTZkdHc3aFEwUHJiNEZKcEFpTHpDUjlycWRvckgwQXBWdWNnWjRLekVib1JEQ3VUR0pjQjc?oc=5","date":"2025-11-11","type":"pipeline","source":"orfonline.org","summary":"Quad Cooperation in Biotechnology: A New Frontier for Health Security in the Indo-Pacific - orfonline.org","headline":"Quad Cooperation in Biotechnology: A New Frontier for Health Security in the Indo-Pacific","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}